FDA approves shot that protects infants and toddlers against RSV – NBC 6 South Florida
U.S. officials approved the first long-acting drug to protect babies and toddlers against RSV.
Source: nbcmiami.com
Stay updated with breaking news from John Farley. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
U.S. officials approved the first long-acting drug to protect babies and toddlers against RSV.
U.S. officials approved the first long-acting drug to protect babies and toddlers against RSV.
Nirsevimab indicated for all infants, and for kids up to 2 years at high risk
The Food and Drug Administration has approved a treatment for respiratory syncytial virus, also known as RSV, in infants and toddlers. It would be one of the first preventatives of its kind.
U.S. officials approved the first long-acting drug to protect babies and toddlers against RSV.